Hogan, Michael J. http://orcid.org/0000-0002-6244-2993
Maheshwari, Nikita http://orcid.org/0000-0002-6065-2823
Begg, Bridget E.
Nicastri, Annalisa
Hedgepeth, Emma J.
Muramatsu, Hiromi http://orcid.org/0000-0003-1544-1493
Pardi, Norbert http://orcid.org/0000-0003-1008-6242
Miller, Michael A.
Reilly, Shanelle P. http://orcid.org/0000-0001-9465-706X
Brossay, Laurent http://orcid.org/0000-0002-7497-8488
Lynch, Kristen W.
Ternette, Nicola http://orcid.org/0000-0002-9283-0743
Eisenlohr, Laurence C. http://orcid.org/0000-0002-8475-7910
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | Office of Extramural Research, National Institutes of Health (R21AI153978, R01AI125524, R01AI146101, R01AI153064, R01AI046709, R01AI125524, R21AI153978)
Cancer Research Institute
In addition to CRI: Aileen K. and Brian L. Roberts Family Foundation via the University of Pennsylvania Institute for Immunology & Immune Health
Roy and Diana Vagelos Molecular Life Sciences Program College Alumni Society Research Grant from the University of Pennsylvania
Article History
Received: 8 November 2022
Accepted: 8 September 2023
First Online: 12 October 2023
Competing interests
: N.T. is or has been a paid consultant to Roche Pharma, Enara Bio, Grey Wolf Therapeutics, T-Cypher Bio and Infinitopes on the topic of cancer antigen discovery. All other authors declare no competing interests.